Patents Assigned to PLUS VITECH, S.L.
  • NEUROKININ INHIBITORS SUCH AS APREPITANT FOR TREATING NON SMALL CELL LUNG CARCINOMA OR BREAST CANCER WITHOUT MUTATIONS
    Publication number: 20240082273
    Abstract: The present invention relates to the treatment of: (i) EGFR?/ALK?/ROS1? NSCLC; and/or (ii) ER?/PR?/HER2? breast cancer, using a NK1 inhibitor.
    Type: Application
    Filed: December 3, 2021
    Publication date: March 14, 2024
    Applicant: PLUS VITECH, S.L.
    Inventor: Manuel Vicente Salinas Martin
  • COMBINATION THERAPY FOR TREATMENT OF CANCER
    Publication number: 20220016142
    Abstract: The present invention relates to the treatment of cancer using a combination of (a) a NK inhibitor (b) a checkpoint inhibitor.
    Type: Application
    Filed: December 20, 2019
    Publication date: January 20, 2022
    Applicant: PLUS VITECH, S.L.
    Inventors: Francisco José LÓPEZ-HERNÁNDEZ, Felipe VOCES-SÁNCHEZ, Josep LAMARCA-CIURO, Yaremi QUIRÓS-LUIS, Anna ESTEVE-ARENYS, Laura HIRALDO-GONZÁLEZ, Manuel Vicente SALINAS-MARTÍN
  • NEUROKININ-1 RECEPTOR ANTAGONIST COMPOSITION FOR TREATMENT OF DISEASES AND CONDITIONS OF THE RESPIRATORY TRACT
    Publication number: 20190307694
    Abstract: The present invention relates to a composition comprising a neurokinin-1 receptor antagonist and at least one excipient selected from an oil, a fatty acid or a polyol, as well as to an administration form for administering a formulation, wherein said administration form is selected from: inhalant, nebulization, vapor, smoke or aerosol and comprises said composition. In addition, the invention relates to said composition for use as medicament, said administration form for use as medicament, preferably said composition for use as medicament in the treatment of at least one disease of the respiratory tract, or said administration form for use as medicament in the treatment of at least one disease of the respiratory tract. Moreover, the invention also provides methods for producing said composition and said administration form, as well as a kit of parts comprising said composition and an administration device.
    Type: Application
    Filed: April 19, 2019
    Publication date: October 10, 2019
    Applicants: PLUS VITECH, S.L., SERVICIO ANDALUZ DE SALUD
    Inventors: Antonio Lara Ruiz, Manuel Vicente Salinas Martin
  • NEUROKININ-1 RECEPTOR ANTAGONIST COMPOSITION FOR TREATMENT OF DISEASES AND CONDITIONS OF THE RESPIRATORY TRACT
    Publication number: 20170290774
    Abstract: The present invention relates to a composition comprising a neurokinin-1 receptor antagonist and at least one excipient selected from an oil, a fatty acid or a polyol, as well as to an administration form for administering a formulation, wherein said administration form is selected from: inhalant, nebulization, vapor, smoke or aerosol and comprises said composition. In addition, the invention relates to said composition for use as medicament, said administration form for use as medicament, preferably said composition for use as medicament in the treatment of at least one disease of the respiratory tract, or said administration form for use as medicament in the treatment of at least one disease of the respiratory tract. Moreover, the invention also provides methods for producing said composition and said administration form, as well as a kit of parts comprising said composition and an administration device.
    Type: Application
    Filed: July 24, 2015
    Publication date: October 12, 2017
    Applicants: PLUS VITECH, S.L., SERVICIO ANDALUZ DE SALUD
    Inventors: Antonio Lara Ruiz, Manuel Vicente Salinas Martín